Hennion & Walsh Asset Management, Inc.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1861642
Parsippany, NJ
Position in REGN
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$445,831
-$104,288 QoQ
Shares Held
715
+0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#834
of 1,322 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Hennion & Walsh Asset Management, Inc. holds $200,308,891 across 60 Biotechnology names. REGN ranks #57 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
48,019 | $11,571,138 | |
| 2 | CELC |
Celcuity Inc.
|
100,368 | $10,500,500 | |
| 3 | URGN |
UroGen Pharma Ltd.
|
276,696 | $10,182,412 | |
| 4 | TVTX |
Travere Therapeutics, Inc.
|
171,470 | $9,741,210 | |
| 5 | SNDX |
Syndax Pharmaceuticals Inc
|
342,883 | $7,495,422 | |
| 6 | QURE |
uniQure N.V.
|
142,113 | $6,545,724 | |
| 7 | KURA |
Kura Oncology, Inc.
|
568,845 | $6,240,229 | |
| 8 | ARDX |
Ardelyx, Inc.
|
1,211,690 | $6,179,619 |
All Filings in REGN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $445,831 | 715 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $550,119 | 712 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $785,763 | 1,018 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $588,696 | 1,047 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,182,825 | 2,253 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,486,000 | 2,343 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $2,212,496 | 3,106 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $3,161,078 | 3,007 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $2,609,707 | 2,483 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $2,276,288 | 2,365 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $1,703,004 | 1,939 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $1,312,621 | 1,595 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $898,893 | 1,251 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $759,223 | 924 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $1,497,813 | 2,076 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $1,517,580 | 2,203 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,455,953 | 2,463 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $2,479,391 | 3,550 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $2,164,219 | 3,427 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,980,754 | 3,273 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,593,514 | 2,853 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,139,794 | 2,409 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||